Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication September 27, 2007
- Accepted for publication December 6, 2007
- Published online March 28, 2008.
Article Versions
- previous version (March 14, 2008 - 11:49).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2008 by Society of Nuclear Medicine
Author Information
- 1Department of Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands; 2Center for Radiopharmaceutical Science, ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland; and 3Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
- For correspondence or reprints contact: Cristina Müller, PhD, Department of Nuclear Medicine, Erasmus Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. E-mail: cristina.mueller{at}psi.ch
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Immunotherapy with Immunocytokines and PD-1 Blockade Enhances the Anticancer Activity of Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX
- Immunotherapy with immunocytokines and PD-1 blockade enhances the anticancer activity of small molecule-drug conjugates targeting carbonic anhydrase IX
- Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma
- 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy
- DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid-Targeted 177Lu-Radionuclide Tumor Therapy in Mice
- Folic Acid Conjugates for Nuclear Imaging of Folate Receptor-Positive Cancer
- A New 18F-Labeled Folic Acid Derivative with Improved Properties for the PET Imaging of Folate Receptor-Positive Tumors